It is important to be honest about the evidence base: much of the research on BPC-157 and thymosin beta-4 comes from preclinical and animal studies, and large long-term human trials are still limited
list prices (2025): $900$1,300 per month without insurance $11,000$16,000 per year at retail pricing Manufacturer coupons typically expire after 612 months Coverage reality: Medicare: limited obesity coverage Medicaid: varies by state Employer plans: increasingly restrictive prior authorization Weight regain often occurs after discontinuation Projected pricing trends: Near-term (35 years): modest price erosion, not collapse Medium-term (510 years): biosimilars and next-gen entrants may reduce prices 3050% Long-term: combination therapies likely raise per-patient spend again This is not a short-course drug market
Native amylin has a half-life of roughly 13 minutes
In 2026, pricing can vary significantly depending on the platform, the medication prescribed, and whether ongoing care is included
Think of it like a key fitting into a lock and turning it
GLP-1 R (40mg) $379.00 GLP-1 R (40mg) is a 99% pure , research-grade peptide designed for scientific studies on insulin sensitivity , metabolic health , and type 2 diabetes management
